Pfizer Inc. is a global pharmaceutical company headquartered in New York City, United States. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart and has since become one of the largest pharmaceutical companies in the world.

Pfizer’s market capitalization stands at approximately $309 billion USD, making it one of the largest pharmaceutical companies in the world.

Pfizer patents are diverse, covering a range of IPC classifications from Medicinal preparations containing organic active ingredients (A61K31) to Medicinal preparations characterised by special physical form (A61K9). Pfizer stats reveal that the company not only focuses on current medical needs but also paves the way for future advancements.

Comparing different aspects of pfizer patents, such as Medicinal Preparations and Methods for Processes for Preparing or Treating Body Fluids, highlights the company’s foresight in areas like medical devices and pharmaceutical industry. These trends are indicative of where pfizer inventions are steering the future of technology.

The Chart below depicts the patents with most number of forward citations. These patents are likely to be the source of advancement in the domain and can be considered as valuable and core inventions.

Pfizer Inc., with its extensive patent portfolio covering a range of innovative technologies, stands as a key player in the pharmaceutical industry. The company has successfully secured a multitude of patents worldwide, emphasizing advancements in medicinal preparations and medical devices.

The data from 2013 to 2023 shows a proactive approach in patent applications across various countries, though the success rate has varied. Pfizer’s forward-thinking in addressing future medical needs is evident from its diverse patent classifications and its investment in emerging technologies, solidifying its role in shaping the future of healthcare and medical science.

Note: This Data is extracted from 2013 to 2023 and on the basis of patent families.